- Home
- BNR vs NYC Comparison
BNR vs NYC Comparison
Compare BNR & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- NYC
- Stock Information
- Founded
- BNR 2014
- NYC 2013
- Country
- BNR China
- NYC United States
- Employees
- BNR N/A
- NYC N/A
- Industry
- BNR Medical Specialities
- NYC Real Estate
- Sector
- BNR Health Care
- NYC Finance
- Exchange
- BNR Nasdaq
- NYC Nasdaq
- Market Cap
- BNR 29.1M
- NYC 24.9M
- IPO Year
- BNR 2020
- NYC N/A
- Fundamental
- Price
- BNR $3.20
- NYC $14.33
- Analyst Decision
- BNR
- NYC
- Analyst Count
- BNR 0
- NYC 0
- Target Price
- BNR N/A
- NYC N/A
- AVG Volume (30 Days)
- BNR 38.8K
- NYC 6.5K
- Earning Date
- BNR 06-06-2025
- NYC 08-08-2025
- Dividend Yield
- BNR N/A
- NYC N/A
- EPS Growth
- BNR N/A
- NYC N/A
- EPS
- BNR N/A
- NYC N/A
- Revenue
- BNR $72,112,038.00
- NYC $58,397,000.00
- Revenue This Year
- BNR $136.32
- NYC $8.40
- Revenue Next Year
- BNR N/A
- NYC $1.62
- P/E Ratio
- BNR N/A
- NYC N/A
- Revenue Growth
- BNR 0.53
- NYC N/A
- 52 Week Low
- BNR $2.18
- NYC $7.55
- 52 Week High
- BNR $7.90
- NYC $15.00
- Technical
- Relative Strength Index (RSI)
- BNR 48.34
- NYC 72.15
- Support Level
- BNR $3.06
- NYC $12.55
- Resistance Level
- BNR $3.50
- NYC $15.20
- Average True Range (ATR)
- BNR 0.36
- NYC 1.05
- MACD
- BNR -0.04
- NYC 0.49
- Stochastic Oscillator
- BNR 20.16
- NYC 86.37
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.